Aspen Aerogels (ASPN) Company Overview

The mean of analysts' price targets for Aspen Aerogels (ASPN) points to a 120.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Aspen Aerogels (ASPN) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.10 per share. This compares to loss of $0.19 per share a year ago.

Here is how Aspen Aerogels (ASPN) and Heidelberg Materials AG Unsponsored ADR (HDELY) have performed compared to their sector so far this year.

Aspen Aerogels, Inc. (NYSE:ASPN ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Neal Baranosky - Senior Director, Head-Investor Relations & Corporate Strategy Don Young - President & Chief Executive Officer Ricardo Rodriguez - Chief Financial Officer & Treasurer Conference Call Participants George Gianarikas - Canaccord Colin Rusch - Oppenheimer Ryan Pfingst - B. Riley Dave Anderson - Barclays Eric Stine - Craig-Hallum Tom Curran - Seaport Research Partners Alex Potter - Piper Sandler Sameer Joshi - H.C.

Aspen Aerogels (ASPN) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to loss of $0.22 per share a year ago.

Brinker (EAT), Aspen (ASPN) and Coinbase (COIN) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Here is how Aspen Aerogels (ASPN) and Quanta Services (PWR) have performed compared to their sector so far this year.

Aspen Aerogels (ASPN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).